BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21364961)

  • 21. CHK2-independent induction of telomere dysfunction checkpoints in stem and progenitor cells.
    Nalapareddy K; Choudhury AR; Gompf A; Ju Z; Ravipati S; Leucht T; Lechel A; Rudolph KL
    EMBO Rep; 2010 Aug; 11(8):619-25. PubMed ID: 20577265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms.
    Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D
    J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomeres and telomerase in stem cells during aging and disease.
    Ju Z; Rudolph KL
    Genome Dyn; 2006; 1():84-103. PubMed ID: 18724055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation.
    Leri A; Franco S; Zacheo A; Barlucchi L; Chimenti S; Limana F; Nadal-Ginard B; Kajstura J; Anversa P; Blasco MA
    EMBO J; 2003 Jan; 22(1):131-9. PubMed ID: 12505991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA damage response, checkpoint activation and dysfunctional telomeres: face to face between mammalian cells and Drosophila.
    Cipressa F; Cenci G
    Tsitologiia; 2013; 55(4):211-7. PubMed ID: 23875450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomere and telomerase in stem cells: relevance in ageing and disease.
    Choudhary B; Karande AA; Raghavan SC
    Front Biosci (Schol Ed); 2012 Jan; 4(1):16-30. PubMed ID: 22202040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Senescence and immortalization: role of telomeres and telomerase.
    Shay JW; Wright WE
    Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olovnikov, Telomeres, and Telomerase. Is It Possible to Prolong a Healthy Life?
    Yegorov YE
    Biochemistry (Mosc); 2023 Nov; 88(11):1704-1718. PubMed ID: 38105192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomere shortening impairs regeneration of the olfactory epithelium in response to injury but not under homeostatic conditions.
    Watabe-Rudolph M; Begus-Nahrmann Y; Lechel A; Rolyan H; Scheithauer MO; Rettinger G; Thal DR; Rudolph KL
    PLoS One; 2011; 6(11):e27801. PubMed ID: 22110763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer.
    Artandi SE; Attardi LD
    Biochem Biophys Res Commun; 2005 Jun; 331(3):881-90. PubMed ID: 15865944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
    Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
    Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
    Farazi PA; Glickman J; Horner J; Depinho RA
    Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice.
    Jaskelioff M; Muller FL; Paik JH; Thomas E; Jiang S; Adams AC; Sahin E; Kost-Alimova M; Protopopov A; Cadiñanos J; Horner JW; Maratos-Flier E; Depinho RA
    Nature; 2011 Jan; 469(7328):102-6. PubMed ID: 21113150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of telomere shortening during lifespan.
    Henriques CM; Ferreira MG
    Curr Opin Cell Biol; 2012 Dec; 24(6):804-8. PubMed ID: 23127607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
    Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.
    Begus-Nahrmann Y; Hartmann D; Kraus J; Eshraghi P; Scheffold A; Grieb M; Rasche V; Schirmacher P; Lee HW; Kestler HA; Lechel A; Rudolph KL
    J Clin Invest; 2012 Jun; 122(6):2283-8. PubMed ID: 22622037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soothing the watchman: telomerase reduces the p53-dependent cellular stress response.
    Beliveau A; Yaswen P
    Cell Cycle; 2007 Jun; 6(11):1284-7. PubMed ID: 17534147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere dysfunction: multiple paths to the same end.
    Harrington L; Robinson MO
    Oncogene; 2002 Jan; 21(4):592-7. PubMed ID: 11850784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of telomere-dependent "senescence-like" arrest in mouse embryonic fibroblasts.
    Espejel S; Blasco MA
    Exp Cell Res; 2002 Jun; 276(2):242-8. PubMed ID: 12027454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.